Intermittent pneumatic thigh compression for the treatment of lower limb wounds (IPCOTT): a randomised control trial

Bosanquet, David C. ORCID: https://orcid.org/0000-0003-2304-0489, Davies, Jane H., Ivins, Nicola, Bradbury, Sarah, Kettley, Kirsty, Cocks, Kim and Harding, Keith 2026. Intermittent pneumatic thigh compression for the treatment of lower limb wounds (IPCOTT): a randomised control trial. Journal of Wound Care 35 (10) , pp. 901-914. 10.12968/jowc.2026.0047

Full text not available from this repository.

Abstract

Objective: Hard-to-heal (chronic) venous leg ulcers (VLUs) are challenging to heal with standard of care (SoC) alone. This study evaluated whether adding a thigh-administered intermittent pneumatic compression (IPC) device (WoundExpress, Huntleigh Healthcare Ltd., UK) to SoC improved outcomes in patients with hard-to-heal venous or mixed leg ulcers (venous and arterial), was suitable for home use and was safe. Method: A multicentre, pragmatic, open-label, randomised controlled trial (RCT) was conducted across the UK, US, Germany and France. Adults with hard-to-heal lower limb VLUs and mixed ulcers already receiving compression were randomised 1:1 to adjunctive IPC (two hours/day; intervention) plus SoC, or SoC alone (control), for 16 weeks. The primary outcome was percentage change in wound area. Secondary outcomes included: complete healing; wound pain; quality of life (QoL); acceptability; usage; and safety. Results: A total of 136 patients were randomised (n=65 IPC; n=71 control); 116 patients completed the study. Median wound area reduction at 16 weeks was similar: (intervention: 64.0% versus control: 67.7%; p=0.35). Complete healing occurred in 16.9% (IPC) and 18.3% (control) patients (p=0.80). Pain scores and QoL improved modestly in both groups, with no between-group differences. The IPC device was well tolerated: 64% of patients rated it ‘very good’ or ‘excellent’. Mean use was ~2.0 hours/day, as reported in patient diaries. Adverse events were primarily mild and comparable (54% IPC; 59% control); only one mild event was device-related. Conclusion: In this RCT, thigh-administered IPC did not improve healing beyond SoC in this patient population, although it was safe, well-tolerated, and feasible for home use.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Publisher:	MA Healthcare
ISSN:	0969-0700
Last Modified:	28 Oct 2026 14:30
URI:	https://orca.cardiff.ac.uk/id/eprint/190504

Actions (repository staff only)

Edit Item